P01KRASG12C 01
Alternative Names: P 01 KRASG12C 01; P01KRASG12C_01Latest Information Update: 17 Nov 2023
At a glance
- Originator PRAMOMOLECULAR
- Class Antineoplastics; Drug conjugates; Small interfering RNA
- Mechanism of Action RNA interference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Non-small cell lung cancer